InjectionClinical Overview
Tigecycline is a first-in-class glycylcycline antibiotic structurally derived from minocycline. It circumvents major tetracycline resistance mechanisms (efflux pumps and ribosomal protection) by binding to the 30S ribosomal subunit with 5-fold higher affinity. Displays broad activity against multidrug-resistant pathogens including MRSA, VRE, ESBL-producing enterobacteria, and carbapenem-resistant Acinetobacter. Indicated for complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administered exclusively in hospital/ICU settings via slow intravenous infusion over 30 to 60 minutes after reconstitution and dilution in 0.9% Normal Saline or 5% Dextrose. Initial loading dose of 100 mg followed by 50 mg every 12 hours.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Severe nausea and vomiting (up to 30% of patients), diarrhea, headache, abdominal pain. Rare/Severe: FDA Boxed Warning: Increased risk of all-cause mortality; acute pancreatitis, severe hepatic cholestasis/failure, and pseudotumor cerebri.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
FDA Boxed Warning: Tigecycline is associated with an increase in all-cause mortality compared to comparator treatments; reserve for situations where alternative treatments are not suitable. Avoid in patients with severe hepatic impairment without dose adjustment. High risk of treatment failure in bacteremia/pneumonia due to low serum concentrations.
Schedule H1 (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.